- List
- By Topic
- On Map
- Search Details

antineoplastons
Need help? See RSS Feeds
Choose a feed type:

antineoplastons (65 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT02988726 | Terminated | Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
3 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT02988726 | BC-BT-19 | March 1999 | August 2001 | August 2001 | December 9, 2016 | July 26, 2017 |
|
|||
2 | NCT02864888 | Not yet recruiting | Effect of Antineoplaston Therapy on the QT/QTc Interval In Subjects With Diffuse, Intrinsic, Brainstem Glioma |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
30 | All | 3 Years to 21 Years (Child, Adult) | NCT02864888 | BRI-BT-53 | DBSG | June 1, 2020 | December 2021 | December 2021 | August 12, 2016 | October 16, 2018 | |||
3 | NCT00003485 | Terminated | Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
15 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003485 | CDR0000066523 BC-CO-02 |
April 10, 1996 | May 11, 2003 | May 11, 2003 | January 27, 2003 | September 28, 2017 |
|
||||
4 | NCT00003483 | Terminated Has Results |
Antineoplaston Therapy in Treating Patients With Meningioma |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
3 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003483 | CDR0000066521 BC-BT-28 |
June 1998 | March 2004 | March 2004 | January 27, 2003 | August 24, 2017 | February 17, 2017 |
|
||
5 | NCT00003458 | Completed Has Results |
Antineoplaston Therapy in Treating Children With Brain Tumors |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
34 | All | 6 Months to 18 Years (Child, Adult) | NCT00003458 | CDR0000066490 BC-BT-10 |
September 1996 | September 2014 | September 2014 | January 27, 2003 | February 2, 2018 | January 19, 2017 |
|
||
6 | NCT00003479 | Terminated Has Results |
Antineoplaston Therapy in Treating Patients With Ependymoma |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
9 | All | 6 Months to 99 Years (Child, Adult, Older Adult) | NCT00003479 | CDR0000066516 BC-BT-24 |
July 1966 | October 2000 | October 2000 | January 27, 2003 | August 24, 2017 | February 17, 2017 |
|
||
7 | NCT00003457 | Completed Has Results |
Antineoplaston Therapy in Treating Patients With Brain Tumors |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
40 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003457 | CDR0000066489 BC-BT-9 |
July 1996 | February 2012 | February 2012 | January 27, 2003 | August 22, 2017 | December 16, 2016 |
|
||
8 | NCT00003454 | Terminated | Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
19 | Female | 18 Years to 99 Years (Adult, Older Adult) | NCT00003454 | CDR0000066486 BC-BR-12 |
March 18, 1996 | December 28, 2002 | December 28, 2002 | January 27, 2003 | September 28, 2017 |
|
||||
9 | NCT00003459 | Completed Has Results |
Antineoplaston Therapy in Treating Patients With Brain Stem Glioma |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
40 | All | 6 Months to 99 Years (Child, Adult, Older Adult) | NCT00003459 | CDR0000066491 BC-BT-11 |
March 1996 | September 2007 | September 2007 | January 27, 2003 | March 14, 2018 | October 12, 2016 |
|
||
10 | NCT00003497 | Terminated | Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
9 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003497 | CDR0000066536 BC-LA-10 |
August 21, 1996 | February 2, 1998 | February 2, 1998 | January 27, 2003 | February 2, 2018 |
|
||||
11 | NCT00003537 | Completed Has Results |
Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
19 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003537 | CDR0000066585 BC-BT-8 |
AA | April 1995 | October 2008 | October 2008 | January 27, 2003 | August 24, 2017 | February 20, 2017 |
|
|
12 | NCT00003476 | Terminated Has Results |
Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
8 | All | 6 Months to 18 Years (Child, Adult) | NCT00003476 | CDR0000066513 BC-BT-22 |
March 1996 | January 2012 | January 2012 | January 27, 2003 | August 24, 2017 | April 10, 2017 |
|
||
13 | NCT00003468 | Completed Has Results |
Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
11 | All | 6 Months to 17 Years (Child) | NCT00003468 | CDR0000066504 BC-BT-13 |
July 1996 | July 2004 | July 2004 | January 27, 2003 | August 24, 2017 | November 10, 2016 |
|
||
14 | NCT00003472 | Terminated Has Results |
Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
13 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003472 | CDR0000066509 BC-BT-17 |
May 1996 | September 2007 | September 2007 | January 27, 2003 | March 21, 2018 | December 13, 2017 |
|
||
15 | NCT00003535 | Terminated Has Results |
Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
9 | All | 6 Months to 18 Years (Child, Adult) | NCT00003535 | CDR0000066582 BC-BT-06 |
April 1994 | January 1998 | January 1998 | January 27, 2003 | March 21, 2018 | December 13, 2017 |
|
||
16 | NCT00003452 | Terminated | Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder |
|
|
Interventional |
Phase 2 |
|
Other |
|
4 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003452 | CDR0000066483 BC-BL-02 |
May 6, 1996 | May 4, 1998 | May 4, 1998 | January 27, 2003 | September 28, 2017 |
|
||||
17 | NCT00003516 | Terminated | Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
16 | Male | 18 Years to 99 Years (Adult, Older Adult) | NCT00003516 | CDR0000066559 BC-PR-5 |
March 27, 1996 | March 18, 2004 | March 18, 2004 | January 27, 2003 | February 2, 2018 |
|
||||
18 | NCT00003469 | Terminated Has Results |
Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
4 | All | 6 Months to 17 Years (Child) | NCT00003469 | CDR0000066505 BC-BT-14 |
February 1996 | May 2003 | May 2003 | January 27, 2003 | August 24, 2017 | March 7, 2017 |
|
||
19 | NCT00003477 | Completed Has Results |
Antineoplaston Therapy in Treating Children With Visual Pathway Glioma |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
12 | All | 6 Months to 17 Years (Child) | NCT00003477 | CDR0000066514 BC-BT-23 |
VPG | June 1996 | May 2008 | May 2008 | January 27, 2003 | August 24, 2017 | December 16, 2016 |
|
|
20 | NCT00003511 | Terminated | Antineoplaston Therapy in Treating Patients With Multiple Myeloma |
|
|
Interventional |
Phase 2 |
|
Other |
|
5 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003511 | CDR0000066554 BC-MM-2 |
April 4, 1996 | October 21, 1999 | October 21, 1999 | January 27, 2003 | February 2, 2018 |
|
||||
21 | NCT00003530 | Terminated | Antineoplaston Therapy in Treating Patients With Primary Liver Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
3 | All | 14 Years to 99 Years (Child, Adult, Older Adult) | NCT00003530 | CDR0000066577 BC-HE-2 |
March 21, 1977 | October 17, 1999 | October 17, 1999 | January 27, 2003 | November 21, 2017 |
|
||||
22 | NCT00003509 | Terminated | Antineoplaston Therapy in Treating Patients With Stage IV Melanoma |
|
|
Interventional |
Phase 2 |
|
Other |
|
13 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003509 | CDR0000066552 BC-ME-2 |
March 27, 1996 | February 14, 2005 | February 14, 2005 | January 27, 2003 | January 31, 2018 |
|
||||
23 | NCT00003460 | Completed Has Results |
Antineoplaston Therapy in Treating Children With Primitive Neuroectodermal Tumors |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
13 | All | 6 Months to 17 Years (Child) | NCT00003460 | CDR0000066492 BC-BT-12 |
PNET | April 1996 | February 2005 | February 2005 | January 27, 2003 | August 24, 2017 | November 10, 2016 |
|
|
24 | NCT00003524 | Terminated | Antineoplaston Therapy in Treating Patients With Stomach Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
1 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003524 | CDR0000066568 BC-ST-02 |
October 4, 1996 | August 24, 1998 | August 24, 1998 | January 27, 2003 | September 29, 2017 |
|
||||
25 | NCT00003521 | Terminated | Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma |
|
|
Interventional |
Phase 2 |
|
Other |
|
14 | All | 6 Months to 99 Years (Child, Adult, Older Adult) | NCT00003521 | CDR0000066565 BC-SA-02 |
June 14, 1996 | August 30, 2003 | August 30, 2003 | January 27, 2003 | September 29, 2017 |
|
||||
26 | NCT00003498 | Terminated | Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma |
|
|
Interventional |
Phase 2 |
|
Other |
|
5 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003498 | CDR0000066537 BC-LY-3 |
December 5, 1996 | November 28, 2000 | November 28, 2000 | January 27, 2003 | February 2, 2018 |
|
||||
27 | NCT00003491 | Terminated | Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
17 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003491 | CDR0000066530 BC-LA-03 |
March 20, 1996 | July 31, 1998 | July 31, 1998 | January 27, 2003 | September 29, 2017 |
|
||||
28 | NCT00003520 | Terminated | Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
15 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003520 | CDR0000066564 BC-RN-02 |
March 27, 1996 | January 23, 2005 | January 23, 2005 | January 27, 2003 | September 29, 2017 |
|
||||
29 | NCT00003531 | Terminated | Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
15 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003531 | CDR0000066578 BC-PA-2 |
March 10, 1996 | July 18, 2005 | July 18, 2005 | January 27, 2003 | November 21, 2017 |
|
||||
30 | NCT00003533 | Terminated | Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
12 | Male | 18 Years to 99 Years (Adult, Older Adult) | NCT00003533 | CDR0000066580 BC-PR-4 |
February 27, 1996 | December 31, 1999 | December 31, 1999 | January 27, 2003 | December 12, 2017 |
|
||||
31 | NCT00003453 | Terminated Has Results |
Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
6 | All | 6 Months to 99 Years (Child, Adult, Older Adult) | NCT00003453 | CDR0000066485 BC-AD-02 |
August 21, 1996 | July 5, 2011 | July 5, 2011 | January 27, 2003 | May 9, 2018 | May 9, 2018 |
|
||
32 | NCT00003489 | Terminated | Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
7 | All | 16 Years to 99 Years (Child, Adult, Older Adult) | NCT00003489 | CDR0000066527 BC-HN-02 |
May 6, 1996 | April 3, 1998 | April 3, 1998 | January 27, 2003 | November 21, 2017 |
|
||||
33 | NCT00003532 | Terminated | Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
7 | Female | 18 Years to 99 Years (Adult, Older Adult) | NCT00003532 | CDR0000066579 BC-OV-2 |
March 5, 1996 | October 18, 2002 | October 18, 2002 | January 27, 2003 | December 12, 2017 |
|
||||
34 | NCT00003522 | Terminated | Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine |
|
|
Interventional |
Phase 2 |
|
Other |
|
1 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003522 | CDR0000066566 BC-SI-02 |
August 13, 1997 | December 14, 1997 | December 14, 1997 | January 27, 2003 | September 29, 2017 |
|
||||
35 | NCT00003471 | Terminated Has Results |
Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
7 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003471 | CDR0000066508 BC-BT-16 |
March 1996 | July 2003 | July 2003 | January 27, 2003 | March 22, 2018 | December 13, 2017 |
|
||
36 | NCT00003499 | Terminated | Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma |
|
|
Interventional |
Phase 2 |
|
Other |
|
31 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003499 | CDR0000066538 BC-LY-6 |
March 6, 1996 | September 13, 2003 | September 13, 2003 | January 27, 2003 | December 12, 2017 |
|
||||
37 | NCT00003526 | Terminated | Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin |
|
|
Interventional |
Phase 2 |
|
Other |
|
8 | All | 6 Months to 99 Years (Child, Adult, Older Adult) | NCT00003526 | CDR0000066570 BC-UP-2 |
March 18, 1996 | February 2, 2005 | February 2, 2005 | January 27, 2003 | December 12, 2017 |
|
||||
38 | NCT00003534 | Withdrawn | Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
0 | Male | 18 Years to 99 Years (Adult, Older Adult) | NCT00003534 | CDR0000066581 BC-PR-8 |
October 11, 1996 | February 20, 1997 | February 20, 1997 | January 27, 2003 | January 31, 2018 |
|
||||
39 | NCT00003495 | Terminated | Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
7 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003495 | CDR0000066534 BC-LA-06 |
March 27, 1996 | November 4, 2003 | November 4, 2003 | January 27, 2003 | September 28, 2017 |
|
||||
40 | NCT00003494 | Terminated | Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
4 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003494 | CDR0000066533 BC-LA-5 |
March 26, 1996 | May 26, 2002 | May 26, 2002 | January 27, 2003 | January 31, 2018 |
|
||||
41 | NCT00003513 | Terminated | Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma |
|
|
Interventional |
Phase 2 |
|
Other |
|
3 | All | 6 Months to 99 Years (Child, Adult, Older Adult) | NCT00003513 | CDR0000066556 BC-NB-2 |
December 16, 1996 | March 29, 1999 | March 29, 1999 | January 27, 2003 | September 28, 2017 |
|
||||
42 | NCT00003470 | Completed Has Results |
Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
27 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003470 | CDR0000066507 BC-BT-15 |
AA | March 1996 | December 2008 | December 2009 | January 27, 2003 | August 24, 2017 | December 16, 2016 |
|
|
43 | NCT00003456 | Completed Has Results |
Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
40 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003456 | CDR0000066488 BRI-BT-07 |
March 14, 1995 | December 7, 2004 | December 7, 2004 | January 27, 2003 | March 22, 2018 | December 13, 2017 |
|
||
44 | NCT00003492 | Terminated | Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
9 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003492 | CDR0000066531 BC-LA-4 |
April 10, 1996 | December 1, 2000 | December 1, 2000 | January 27, 2003 | December 12, 2017 |
|
||||
45 | NCT00003525 | Terminated | Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva |
|
|
Interventional |
Phase 2 |
|
Other |
|
8 | Female | 18 Years to 99 Years (Adult, Older Adult) | NCT00003525 | CDR0000066569 BC-UC-02 |
June 3, 1996 | January 22, 1998 | January 22, 1998 | January 27, 2003 | September 29, 2017 |
|
||||
46 | NCT00003496 | Terminated | Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
4 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003496 | CDR0000066535 BC-LA-07 |
March 7, 1996 | February 5, 2004 | February 5, 2004 | January 27, 2003 | September 28, 2017 |
|
||||
47 | NCT00003475 | Completed Has Results |
Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
40 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003475 | CDR0000066512 BC-BT-21 |
February 1996 | May 2011 | May 2011 | January 27, 2003 | August 24, 2017 | December 19, 2016 |
|
||
48 | NCT00003474 | Completed Has Results |
Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
40 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003474 | CDR0000066511 BRI-BT-20 |
March 14, 1996 | June 21, 2003 | June 21, 2003 | January 27, 2003 | March 22, 2018 | December 13, 2017 |
|
||
49 | NCT00003512 | Withdrawn | Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia |
|
|
Interventional |
Phase 2 |
|
Other |
|
0 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003512 | CDR0000066555 BC-MW-2 |
February 18, 1999 | April 26, 2000 | April 26, 2000 | January 27, 2003 | February 2, 2018 |
|
||||
50 | NCT00003501 | Terminated | Antineoplaston Therapy in Treating Patients With High-Grade Stage II - Stage IV Non-Hodgkin's Lymphoma |
|
|
Interventional |
Phase 2 |
|
Other |
|
2 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003501 | CDR0000066541 BC-LY-08 |
April 10, 1996 | July 2, 2003 | July 2, 2003 | January 27, 2003 | February 2, 2018 |
|
||||
51 | NCT00003500 | Terminated | Antineoplaston Therapy in Treating Patients With Intermediate-Grade Stage II - IV Non-Hodgkin's Lymphoma |
|
|
Interventional |
Phase 2 |
|
Other |
|
12 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003500 | CDR0000066540 BC-LY-07 |
March 11, 1996 | June 16, 2000 | June 16, 2000 | January 27, 2003 | February 2, 2018 |
|
||||
52 | NCT00003515 | Terminated | Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors |
|
|
Interventional |
Phase 2 |
|
Other |
|
1 | All | 6 Months to 99 Years (Child, Adult, Older Adult) | NCT00003515 | CDR0000066558 BC-PN-02 |
December 12, 1996 | January 3, 1997 | January 3, 1997 | January 27, 2003 | September 29, 2017 |
|
||||
53 | NCT02887040 | Not yet recruiting | Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem Glioma |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
92 | All | 3 Years to 99 Years (Child, Adult, Older Adult) | NCT02887040 | BRI-BT-52 | DIPG | June 1, 2019 | June 2022 | June 2023 | September 1, 2016 | July 11, 2018 | |||
54 | NCT00003473 | Completed Has Results |
Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
20 | All | 18 Years to 99 Years (Adult, Older Adult) | NCT00003473 | CDR0000066510 BC-BT-18 |
March 1996 | August 2007 | August 2007 | January 27, 2003 | January 17, 2018 | November 1, 2016 |
|
||
55 | NCT00003508 | Terminated | Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
40 | All | 1 Year and older (Child, Adult, Older Adult) | NCT00003508 | CDR0000066551 BC-MA-2 |
March 1996 | December 2011 | January 27, 2003 | December 18, 2013 |
|
||||
56 | NCT00003487 | Terminated | Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
40 | All | 18 Years and older (Adult, Older Adult) | NCT00003487 | CDR0000066525 BC-ES-2 |
May 1996 | December 2011 | January 27, 2003 | December 18, 2013 |
|
||||
57 | NCT02742883 | Active, not recruiting | A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG) |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
1 | All | 3 Months to 99 Years (Child, Adult, Older Adult) | NCT02742883 | BRI-BT-55 | April 2016 | March 2020 | February 2021 | April 19, 2016 | July 13, 2018 |
|
|||
58 | NCT00003486 | Withdrawn | Antineoplaston Therapy in Treating Patients With Colon Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
0 | All | 18 Years and older (Adult, Older Adult) | NCT00003486 | BC-CO-3 CDR0000066524 |
January 27, 2003 | July 10, 2013 |
|
|||||||
59 | NCT00003455 | Withdrawn | Antineoplaston Therapy in Treating Women With Advanced Breast Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
0 | All | 18 Years and older (Adult, Older Adult) | NCT00003455 | BC-BR-14 CDR0000066487 |
January 27, 2003 | July 10, 2013 |
|
|||||||
60 | NCT00003502 | Withdrawn | Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma |
|
|
Interventional |
Phase 2 |
|
Other |
|
0 | All | 18 Years and older (Adult, Older Adult) | NCT00003502 | BC-LY-9 CDR0000066542 |
January 27, 2003 | July 10, 2013 |
|
|||||||
61 | NCT00003505 | Withdrawn | Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma |
|
|
Interventional |
Phase 2 |
|
Other |
|
0 | All | 18 Years and older (Adult, Older Adult) | NCT00003505 | BC-LY-12 CDR0000066545 |
January 27, 2003 | July 10, 2013 |
|
|||||||
62 | NCT00003517 | Withdrawn | Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
0 | All | 18 Years and older (Adult, Older Adult) | NCT00003517 | BC-PR-6 CDR0000066560 |
January 27, 2003 | July 10, 2013 |
|
|||||||
63 | NCT00003514 | Withdrawn | Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy |
|
|
Interventional |
Phase 2 |
|
Other |
|
0 | All | 18 Years and older (Adult, Older Adult) | NCT00003514 | BC-NE-2 CDR0000066557 |
January 27, 2003 | July 10, 2013 |
|
|||||||
64 | NCT00003536 | Withdrawn | Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
0 | All | Child, Adult, Older Adult | NCT00003536 | BC-BR-10 CDR0000066584 |
January 27, 2003 | July 10, 2013 |
|
|||||||
65 | NCT01260103 | Withdrawn | Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
0 | All | 6 Months to 18 Years (Child, Adult) | NCT01260103 | BRI-BT-54 | December 2011 | December 2016 | December 2018 | December 15, 2010 | July 26, 2017 |
† Study has passed its completion date and status has not been verified in more than two years.